We speculate that ERα facilitates drug resistance mainly through randomly inactivating genes required for killing breast cancer cells in the case of its epigenetic regulation, since ERα-activated-DNMT1 was dominantly involved in drug-induced global DNA hypermethylation. Here, DNMT1 is linked to breast carcinoma.